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In this report we demonstrate that the herpes simplex virus type 1 reiteration element 1 (RE1) (nt:
117158–117353) in concert with its ﬂanking sequences is both a cell speciﬁc and stimulus inducible
regulatory domain. This region of the virus genome and speciﬁcally the RE1 supports differential
reporter gene expression in both baby hamster kidney cells and disassociated rat trigeminal ganglia
and is present within a region that is implicated in regulating latency of the virus in neuronal cells.
Further we demonstrate that this locus is a transcriptional regulatory domain and a target for the
transcription factor CCCTC binding protein.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction which can support cell speciﬁc reporter gene expression in theRepetitive DNA is a common feature of eukaryotic DNA and
many functions have been ascribed to it including a role in tran-
scriptional regulation and modulation of DNA structure [1]. We
have shown that polymorphic repeats, termed variable number
tandem repeats (VNTR), can act as cell speciﬁc and stimulus induc-
ible enhancers in neuronal cells [1–4]. Herpes simplex virus type 1
(HSV-1) primarily infects the host via ﬁbroblasts this is the site
were the lytic phase can occur, while HSV-1 can establish and reac-
tivate from latency in neurons. Therefore, regulation of the HSV-1
lifecycle requires cell speciﬁc enhancers. A role of tandem repeat
DNA as cell speciﬁc elements is reﬂected in many viruses, includ-
ing HSV-1, in which tandem repeats differentially regulate tran-
scription [5].
The rat preprotachykinin-A (TAC1) gene which encodes the
neuropeptide substance P, has an intronic repeat of CCCTCCC,cal Societies. Published by Elsevier
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.context of a reporter gene construct [6]. The TAC1 gene is a stimu-
lus inducible gene in trigeminal ganglia (TG) neurons [7], similarly
reactivation of HSV-1 is stress inducible in TG [8]. Despite both the
constraint on virus genome size, and the inherent instability of tan-
dem repeats, repetitive regions within the HSV-1 genome are con-
served, show copy number variation and are hot spots for
recombination [9–11]. We have identiﬁed a repetitive domain
termed reiteration element 1 (RE1) [12], also known as CCCTC
binding protein (CTCF) repeat long 1 (CTRL1) [13]. This element
has a CT repetitive structure similar to the TAC1 intronic repeat,
Fig. 1A and has been shown to bind to CTCF in latently infected
mouse dorsal root ganglia (DRG) using in vivo ChIP analysis [13].
In addition to the data on the TAC1 gene and HSV-1 RE1 we
have more recently shown that tandem repeats within the human
dopamine and serotonin transporter genes (SLC6A3 and SLC6A4,
respectively) can support differential cell and stimulus inducible
expression in vivo and in vitro [1–4]. One of the transcription fac-
tors that modulates expression of the SLC6A4 repeat domain is
CTCF [3,4], which has a high afﬁnity for the ‘‘CCCTC” element
which is repeated in RE1 [14]. We also wanted to investigate the
RE1 within the context of a larger locus, URI, which spans from
116 401 bp to 117 996 bp of the HSV-1 genome (Fig. 1). The URI
region is located upstream of the latency associated transcript
(LAT) promoter near the unique-long/internal repeat long (UL/IRL)B.V.Open access under CC BY license.
Fig. 1. The loci studied in the context of the HSV-1 genome. There are a number of
genes in this region running in both orientations. References to nucleotide position
are from the HSV-1 genome sequence (NC_001806). (A) The structure of the HSV-1
genome showing proximity of the LAT ( ) and ICP0 (?) genes to the RE1 (IRL
boundary with the unique long (UL) region). The RE1 element is also present in the
TRL region (nt: 9018–9213). (B) The loci to be investigated illustrating the CT rich
RE1 (184 bp) and GC rich U and I regions. (C) The RE1 was cloned into pGL3p and
pGL3c (Promega) upstream of the SV40 promoter (Sac1/Xho sites) (nt: 116 996–
117 360; 364 bp). It was not possible to isolate the RE1 without some ﬂanking
sequence due to the repetitive nature of the sequence. (D) The UI construct was
cloned into pGL3p (1400 bp). (E) The URI construct was cloned into pGL3p
(1595 bp). (F) The RE1 contains 11.5 copies of a CT rich repeat sequence.
Fig. 2. UI and URI are cell speciﬁc domains; CTCF signiﬁcantly activates transcrip-
tional activity of the UI and URI elements in TG. (A) The structure of the inserts UI
and URI in pGL3p. (B) The URI construct is a repressor in ﬁbroblasts and an activator
in TG. The URI sequence was signiﬁcantly activated by over-expressing the
transcription factor CTCF in TG. (C) The UI construct is an activator in ﬁbroblasts
and a repressor in TG, while CTCF only activates in TG. Data shown are an average
from at least two independent experiments performed in no less than four
replicates. Error bars indicate S.E.M. One-way ANOVA indicates that the activating
effect of CTCF is signiﬁcant **P 6 0.01, ***P 6 0.001.
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RE1, URI and UI, which is similar to URI but has the RE1 region re-
moved (Fig. 1), can act as cell speciﬁc and stimulus inducible reg-
ulators of reporter gene expression which could be further
modulated by CTCF.
2. Materials and methods
2.1. Generation of reporter gene constructs
The RE1, UI and URI regions were cloned upstream of the min-
imum SV40 promoter in the pGL3 promoter vector (Fig. 1). The
CTCF expression construct consisted of CTCF cDNA cloned into
the mammalian expression vector pcDNA3 (Invitrogen, San Diego,
CA) and was a kind gift from E. Klenova, University of Essex.
2.2. Tissue culture and transfection
Baby hamster kidney (BHK) ﬁbroblasts were transfected with
Exgen 500 in vitro transfection reagent (Fermentas) using the stan-
dard protocol a transfection efﬁciency of 80–90% was achieved.
BHK ﬁbroblasts were maintained in Glasgow’s medium (Invitro-
gen) supplemented with 10% FCS and 1% (v/v) 100 penicillin/
streptomycin (equates to a ﬁnal concentration of 100 units penicil-
lin/100 lg streptomycin).
Disassociated TG were prepared fromWistar rats (2–5 days old)
and cultured based on a previously published protocol [15]. TG
were transfected using lipofectamine and the standard protocol
was followed (Invitrogen) an average transfection efﬁciency of
60% was achieved. In brief, 1 lg reporter gene and CTCF expression
vector were transfected per 100 000 cells in 24 well plate format. A
minimal TK promoter expressing renillia luciferase (pMLuc-2,
0.1 lg/well, Novagen) was added as an internal control in all
experiments. Reporter gene expression was analyzed 48 h after
transfection using the Dual Luciferase Reporter Assay System (Pro-
mega) and assayed for both luciferase and renillin activity using a
luminometer (GLOMAX 96 microplate luminometer). The mean
normalized luciferase values were calculated together with theSEM (luciferase/renillin). To normalise for transfection efﬁciency
the total DNA concentration was standardized by co-transfection
of reporter constructs with 1 lg of CTCF or 1 lg of pGL3b (Prome-
ga). The CTCF data was normalised to transgene expression from
pGL3p co-transfected with CTCF.
3. Results and discussion
In this communication we demonstrate using transient trans-
fections that the URI domain, UI and RE1 components (Fig. 1) have
different transcriptional activities in ﬁbroblasts and TG (Figs. 2 and
3). The TG used were approximately 70% neuronal (Supplementary
Fig. S1). Interestingly we saw that both UI and URI demonstrate
opposite cell speciﬁc enhancer and repressor properties analogous
to that of the RE1 in the context of pGL3p. PGL3p has a weak pro-
moter supporting reporter gene expression and therefore the
amount of reporter protein produced is dependent on the inserted
regulatory domain. The URI locus can activate transcription in TG,
whereas it strongly inhibits transcription in ﬁbroblasts (Fig. 2).
The RE1 in the context of URI is a repressor in ﬁbroblasts
(Fig. 2B), as it can repress the activation mediated by the UI do-
main. Conversely, the RE1 acts as an enhancer in TG, both alone
and when introduced into the TG speciﬁc repressor UI (Figs. 2B
and 3). The RE1 is a cell speciﬁc enhancer as it supports a 12-fold
increase in reporter gene expression in TG, whereas there was no
signiﬁcant change in ﬁbroblasts (Fig. 3). Therefore, the RE1 has cell
Fig. 3. The RE1 demonstrates cell speciﬁcity; CTCF signiﬁcantly activates tran-
scriptional activity of the RE1 element in ﬁbroblasts. (A) The structure of the RE1
insert in pGL3p. (B) The RE1 sequence was signiﬁcantly activated by over-
expressing the transcription factor CTCF in ﬁbroblasts. Data shown from the RE1
alone are an average from at least two independent experiments performed in no
less than four replicates. Error bars indicate S.E.M. One-way ANOVA indicates that
the activating effect of CTCF is signiﬁcant *P 6 0.05.
Fig. 4. The RE1 can intercept the action of the SV40 enhancer and reduce
transcriptional activity in ﬁbroblasts and TG; CTCF can relieve repression exerted
by RE1C in ﬁbroblasts. (A) The RE1 is inserted between the SV40 enhancer and
promoter in pGL3c. (B) Data shown are an average from at least two independent
experiments performed in no less than triplicate. Two-way ANOVA indicates that
the repressive effect of the RE1 is signiﬁcant **P 6 0.01, ***P 6 0.001.
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ﬂanking sequences.
One of the cellular factors that could affect virus reactivation
is the transcription factor CTCF, as it is responsive to cellular
challenges including UV light [16,17] and is also a target for
physiological stress [4], both of which can induce HSV-1 reactiva-
tion. Furthermore, it has been found that for some regulatory
domains CTCF can act as either an activator or a repressor
depending on the cell type [18]. CTCF activates the RE1 in ﬁbro-
blasts but not in TG (Fig. 3), this could be due to maximal activa-
tion in TG prior to addition of CTCF. The larger UI domain contain
7 consensus sequences for CTCF (Supplementary Fig. S2), either
in isolation or with the RE1 inserted (URI) is a regulatory domain
that can enhance transcription in response to CTCF in TG (Fig. 2).
This cell type speciﬁc response to CTCF, coupled with 15-fold
relief of repression from the UI region in TG (Fig. 2C), demon-
strates that the URI region may act as a neuron speciﬁc enhancer
in response to CTCF. Therefore, changes in CTCF in response to
stress may change the transcriptional activity of this region in
neurons.
In genome wide analyses in Drosophila, CTCF is found to bind
between closely spaced genes, which is an atypical distribution
compared to other insulator proteins and suggest that it plays
an active role in regulating gene activity [19]. CTCF binding
regions are implicated in regulation of changes essential for the
maintenance of latency and reactivation in HSV-1 [13,20,21]. An
activity for CTCF at the UI and URI domains expands the repertoire
of this transcription factor as a regulator of HSV-1 latency [21].
These data suggest the URI domain is an inducible, cell speciﬁc
regulatory domain that could play a role in the regulation of the
HSV-1 lifecycle.
In both ﬁbroblasts and TG the RE1 domain acts as a repressor of
an active enhancer when it was cloned into the pGL3c vector
(Fig. 4B). The pGL3c construct utilises a strong enhancer to drive
high levels of reporter gene expression in many cells. The levels
of expression supported by the RE1C reporter construct are re-
pressed to that supported by pGL3p in ﬁbroblasts (Fig. 4B), whereas
in TG the RE1C construct is repressed 15-fold relative to RE1 cloned
into pGL3p. This suggests that the RE1 acts as an enhancer blocker
in TG and this abrogates the mechanism by which the RE1 activates
transcription. Further, transfection of CTCF into ﬁbroblasts relieves
repression of RE1C whereas in TG no effect is observed. This is anal-ogous to the effect of CTCF on RE1 in pGL3p and suggests that CTCF
has different functions on the RE1 in both cell types (Fig. 4B).
CTCF has been implicated as a major determinant controlling
HSV-1 latency. A chromatin insulator-like element in the HSV-1
LAT intron, CTCF repeat long 2 (CTRL2), has homology to the RE1
and contains nine copies of the CTCCC CTCF consensus. CTRL2
has been shown to bind CTCF and demonstrated enhancer blocking
activity in vitro [13], therefore it appears repeat sequences that can
bind to CTCF may form a secondary structure which confers enhan-
cer blocking activity. In Kaposi’s sarcoma herpes virus, CTCF bind-
ing regions prevent activation of nearby lytic genes [22]. This
function is essential as it regulates spatial separation of permissive
and non-permissive domains preventing inappropriate gene
expression during latency and it may promote the co-ordinated
cascade of gene expression during reactivation. Therefore, the
RE1 in addition to many CTCF binding regions in HSV-1 may be
important to prevent inappropriate activation of viral genes during
latency and reactivation [13]. Although in transient transfections
the DNA may or may not be complexed with histones 48 hours
after transfection, in vivo the HSV-1 genome would be complexed
with histones. The RE1 region has previously been identiﬁed as
binding to nucleosome restructuring proteins, e.g. beta globin
protein 1 (BGP-1) [23], therefore this region may be involved
in remodelling nucleosomal structure, the co-ordination of which
is crucial for the establishment of latency and reactivation of
HSV-1 [20].
Taken together our data suggest this locus is involved in cell
speciﬁc expression, and that the RE1 is key in the regulation of
gene expression. Furthermore, the RE1 can act as an enhancer
blocker, therefore it appears the locus may have different func-
tions during the HSV-1 lifecycle. The data illustrates mechanisms
by which tandem repeats can synergistically interact with their
surrounding sequences to modulate enhancer function in a cell
speciﬁc manner. An activity for CTCF at the UI and URI domains
expands the repertoire of this transcription factor as a regulator
of HSV-1 latency [21]. These data suggest the URI domain is a
stimulus inducible, cell speciﬁc regulatory domain that could play
a role in the regulation of the HSV-1 lifecycle. Indeed, we will
pursue interactions between this locus and other transcription
factors thought to be important in latency and reactivation of
HSV-1.
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